首页> 外文期刊>Vascular Health and Risk Management >High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study
【24h】

High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study

机译:由德国办公室心脏病专家系统管理的急性冠脉综合征患者的治疗依从性高,心脏死亡率低和发病率低:ProAcor研究的1年结果

获取原文
           

摘要

We aimed to assess patient acceptance and effectiveness of a 12-month structured management program in patients after an acute coronary syndrome (ACS) event who were treated in a special setting of office-based cardiologists. The program comprised patient documentation with a specific tool (Bundesverband Niedergelassener Kardiologen [German Federation of Office-Based Cardiologists] cardiac pass with visit scheduling) shared by the hospital physician and the office-based cardiologist, the definition of individual treatment targets, and the systematic information of patients in order to optimize adherence to therapy. Participating centers (36 hospitals, 60 office-based cardiologists) included a total of 1,003 patients with ACS (ST-segment elevation myocardial infarction [STEMI] 44.3%, non-ST-segment elevation myocardial infarction [NSTEMI] 39.5%, unstable angina pectoris [UA] 15.2%, and unspecified 1.0%). During follow-up, treatment rates with cardiac medication remained high in all groups, with dual antiplatelet therapy in 91.0% at 3 months, 90.0% at 6 months, and 82.8% at 12 months, respectively. Twelve months after the inclusion, a total of 798 patients (79.6%) still participated in the program. Eighteen patients (1.8%) had died after discharge from hospital (6 in the STEMI, 12 in the NSTEMI group), while for 58 the status was unknown (5.8%). Based on a conservative approach that considered patients with unknown status as dead, 1-year mortality was 7.6%. Recurrent cardiac events were noted in14.9% at 1 year, with an about equal distribution across STEMI and NSTEMI patients. In conclusion, patients’ acceptance of the ProAcor program as determined by adherence rates over time was high. Treatment rates of recommended medications used for patients with coronary heart disease were excellent. The 1-year mortality rate was comparatively low.
机译:我们的目的是评估急性冠脉综合征(ACS)事件发生后接受特殊心脏病治疗的患者的12个月结构化管理计划的患者接受度和有效性。该计划包括由医院医师和办公室心脏病专家共享的具有特定工具的患者文档(Bundesverband Niedergelassener Kardiologen [德国办公室心脏病专家联合会]带有通过计划的心脏通行证),个人治疗目标的定义以及系统的患者的信息,以优化对治疗的依从性。参与中心(36家医院,60名办公室心脏病专家)包括ACS的1,003例患者(ST段抬高型心肌梗塞[STEMI] 44.3%,非ST段抬高型心肌梗塞[NSTEMI] 39.5%,不稳定型心绞痛) [UA] 15.2%,未指定1.0%)。在随访期间,所有组的心脏药物治疗率均保持较高水平,双重抗血小板治疗在3个月时分别为91.0%,6个月时为90.0%,12个月时为82.8%。纳入后12个月,仍然有798名患者(79.6%)参加了该计划。出院后死亡的有18名患者(1.8%)(STEMI组为6名,NSTEMI组为12名),而58名患者的状态未知(5.8%)。根据保守的方法,将身份不明的患者视为死亡,一年死亡率为7.6%。在1年时,复发性心脏事件的发生率为14.9%,在STEMI和NSTEMI患者中的分布大致相等。总而言之,患者对ProAcor程序的接受程度很高,这取决于一段时间内的依从率。冠心病患者推荐药物的治疗率极高。 1年死亡率较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号